Bradford Whitmore Buys 28,588 Shares of Ultralife (NASDAQ:ULBI) Stock

Ultralife Corporation (NASDAQ:ULBI) Director Bradford Whitmore bought 28,588 shares of the company’s stock in a transaction on Tuesday, December 16th. The stock was bought at an average price of $5.70 per share, for a total transaction of $162,951.60. Following the completion of the purchase, the director owned 1,235,631 shares of the company’s stock, valued at approximately $7,043,096.70. The trade was a 2.37% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Ultralife Trading Up 2.1%

Shares of ULBI stock opened at $5.91 on Thursday. The company has a quick ratio of 1.42, a current ratio of 2.99 and a debt-to-equity ratio of 0.34. The firm has a market cap of $98.40 million, a P/E ratio of 59.10 and a beta of 0.88. The company has a 50 day moving average of $6.15 and a 200-day moving average of $7.10. Ultralife Corporation has a 12-month low of $4.07 and a 12-month high of $9.52.

Ultralife (NASDAQ:ULBI) last announced its quarterly earnings data on Monday, November 17th. The technology company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.21 by ($0.28). Ultralife had a net margin of 0.92% and a return on equity of 1.66%. The firm had revenue of $43.37 million for the quarter, compared to the consensus estimate of $53.00 million.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of ULBI. Truffle Hound Capital LLC bought a new stake in Ultralife during the 2nd quarter valued at $2,245,000. RBF Capital LLC bought a new stake in shares of Ultralife in the 2nd quarter worth approximately $2,020,000. Arrowstreet Capital Limited Partnership lifted its stake in Ultralife by 210.8% in the third quarter. Arrowstreet Capital Limited Partnership now owns 219,018 shares of the technology company’s stock worth $1,494,000 after acquiring an additional 148,542 shares during the period. Teton Advisors LLC purchased a new position in Ultralife during the 3rd quarter valued at $752,000. Finally, Russell Investments Group Ltd. lifted its position in shares of Ultralife by 4,670.9% in the 3rd quarter. Russell Investments Group Ltd. now owns 48,997 shares of the technology company’s stock worth $334,000 after purchasing an additional 47,970 shares during the period. Hedge funds and other institutional investors own 30.68% of the company’s stock.

Wall Street Analysts Forecast Growth

ULBI has been the subject of several research reports. Wall Street Zen downgraded Ultralife from a “strong-buy” rating to a “hold” rating in a research note on Saturday, September 13th. Weiss Ratings restated a “sell (d+)” rating on shares of Ultralife in a research note on Monday. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Ultralife has a consensus rating of “Sell”.

Ultralife Company Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.